NCT00694512

Brief Summary

The purpose of this study is to learn more about how diet affects the hormone ghrelin. Ghrelin is made in the stomach and causes appetite to increase. Learning about ghrelin will help the investigators understand more about obesity.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
51

participants targeted

Target at P25-P50 for not_applicable obesity

Timeline
Completed

Started Feb 2008

Typical duration for not_applicable obesity

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2008

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

June 6, 2008

Completed
4 days until next milestone

First Posted

Study publicly available on registry

June 10, 2008

Completed
2.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2011

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2011

Completed
Last Updated

May 15, 2012

Status Verified

May 1, 2012

Enrollment Period

3.1 years

First QC Date

June 6, 2008

Last Update Submit

May 14, 2012

Conditions

Outcome Measures

Primary Outcomes (1)

  • The primary outcomes for aim 1 are the suppression of total and acylated ghrelin from peak fasting (highest value) level to nadir (lowest level) during the 4 hours after each meal, comparing the obese to the lean subjects.

    every 8 weeks

Secondary Outcomes (1)

  • Area-under-the-curve measurements during the 12 ½ hours of testing for ghrelin and other nutrient and gut-peptides, including glucose, insulin, PYY3-36, and active GLP-1.

    Every 8 weeks

Study Arms (3)

1

PLACEBO COMPARATOR

low fat diet for two weeks.

Dietary Supplement: Low fat diet

2

ACTIVE COMPARATOR

High fat diet for two weeks followed by blood sampling.

Dietary Supplement: High fat diet

3

ACTIVE COMPARATOR

Medium Chain Triglyceride diet

Dietary Supplement: MCT diet

Interventions

Low fat dietDIETARY_SUPPLEMENT

20% fat diet

1
High fat dietDIETARY_SUPPLEMENT

40% fat diet

2
MCT dietDIETARY_SUPPLEMENT

Medium chain triglyceride diet

Also known as: Medium chain triglyceride diet
3

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age 18 or older.
  • Weight stable for at least 3 months.
  • At lifetime maximal body weight.

You may not qualify if:

  • Actively losing weight by diet or exercise.
  • Smokers.
  • Alcohol consumption \> 2 drinks per day.
  • Exercise \> 30 minutes 3 times a week.
  • Prescription drug use (except birth control pills, vitamins, or minerals).
  • Type 2 diabetes.
  • Heart disease, cancer, malabsorptive states, or chronic infections that would affect body weight.
  • Weight \> 300 lbs (exceeds the weight limit of the DEXA machine).
  • Hemoglobin \< 12.0 g/dL for women, \< 13.5 g/dL for men

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Oregon Health & Science University

Portland, Oregon, 97239, United States

Location

MeSH Terms

Conditions

Obesity

Interventions

Diet, Fat-RestrictedDiet, High-Fat

Condition Hierarchy (Ancestors)

OverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Diet TherapyNutrition TherapyTherapeuticsDietNutritional Physiological PhenomenaDiet, Food, and NutritionPhysiological Phenomena

Study Officials

  • Jonathan Q. Purnell, M.D.

    Oregon Health and Science University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
BASIC SCIENCE
Intervention Model
CROSSOVER
Sponsor Type
OTHER

Study Record Dates

First Submitted

June 6, 2008

First Posted

June 10, 2008

Study Start

February 1, 2008

Primary Completion

March 1, 2011

Study Completion

March 1, 2011

Last Updated

May 15, 2012

Record last verified: 2012-05

Locations